These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 35754551)

  • 1. Manufacturing Mesenchymal Stromal Cells for the Treatment of Osteoarthritis in Canine Patients: Challenges and Recommendations.
    Ivanovska A; Wang M; Arshaghi TE; Shaw G; Alves J; Byrne A; Butterworth S; Chandler R; Cuddy L; Dunne J; Guerin S; Harry R; McAlindan A; Mullins RA; Barry F
    Front Vet Sci; 2022; 9():897150. PubMed ID: 35754551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Questions and Challenges in the Development of Mesenchymal Stromal/Stem Cell-Based Therapies in Veterinary Medicine.
    Devireddy LR; Boxer L; Myers MJ; Skasko M; Screven R
    Tissue Eng Part B Rev; 2017 Oct; 23(5):462-470. PubMed ID: 28142381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
    Wuchter P; Bieback K; Schrezenmeier H; Bornhäuser M; Müller LP; Bönig H; Wagner W; Meisel R; Pavel P; Tonn T; Lang P; Müller I; Renner M; Malcherek G; Saffrich R; Buss EC; Horn P; Rojewski M; Schmitt A; Ho AD; Sanzenbacher R; Schmitt M
    Cytotherapy; 2015 Feb; 17(2):128-39. PubMed ID: 24856898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease.
    Calcat-I-Cervera S; Sanz-Nogués C; O'Brien T
    Front Med (Lausanne); 2021; 8():728496. PubMed ID: 34616756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data.
    Rojewski MT; Lotfi R; Gjerde C; Mustafa K; Veronesi E; Ahmed AB; Wiesneth M; Körper S; Sensebé L; Layrolle P; Hellem S; Schrezenmeier H
    Cytotherapy; 2019 Apr; 21(4):468-482. PubMed ID: 30926359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
    Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
    Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in Humans.
    Labedz-Maslowska A; Szkaradek A; Mierzwinski T; Madeja Z; Zuba-Surma E
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Protocol for the Isolation, Culture, and Cryopreservation of Umbilical Cord-Derived Canine Mesenchymal Stromal Cells: Role of Cell Attachment in Long-Term Maintenance.
    Wright A; Snyder L; Knights K; He H; Springer NL; Lillich J; Weiss ML
    Stem Cells Dev; 2020 Jun; 29(11):695-713. PubMed ID: 32148170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers.
    Phinney DG; Galipeau J;
    Cytotherapy; 2019 Jul; 21(7):782-792. PubMed ID: 31182333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials.
    Guess AJ; Daneault B; Wang R; Bradbury H; La Perle KMD; Fitch J; Hedrick SL; Hamelberg E; Astbury C; White P; Overolt K; Rangarajan H; Abu-Arja R; Devine SM; Otsuru S; Dominici M; O'Donnell L; Horwitz EM
    Stem Cells Transl Med; 2017 Oct; 6(10):1868-1879. PubMed ID: 28887912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current good manufacturing practice considerations for mesenchymal stromal cells as therapeutic agents.
    Sanz-Nogués C; O'Brien T
    Biomater Biosyst; 2021 Jun; 2():100018. PubMed ID: 36824657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency.
    Robb KP; Fitzgerald JC; Barry F; Viswanathan S
    Cytotherapy; 2019 Mar; 21(3):289-306. PubMed ID: 30528726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise Review: Stem Cell Trials Using Companion Animal Disease Models.
    Hoffman AM; Dow SW
    Stem Cells; 2016 Jul; 34(7):1709-29. PubMed ID: 27066769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality Control Optimization for Minimizing Security Risks Associated with Mesenchymal Stromal Cell-Based Product Development.
    Rebelatto CLK; Boldrini-Leite LM; Daga DR; Marsaro DB; Vaz IM; Jamur VR; de Aguiar AM; Vieira TB; Furman BP; Aguiar CO; Brofman PRS
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell-based bone tissue engineering for veterinary practice.
    Nantavisai S; Egusa H; Osathanon T; Sawangmake C
    Heliyon; 2019 Nov; 5(11):e02808. PubMed ID: 31844733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production.
    Camilleri ET; Gustafson MP; Dudakovic A; Riester SM; Garces CG; Paradise CR; Takai H; Karperien M; Cool S; Sampen HJ; Larson AN; Qu W; Smith J; Dietz AB; van Wijnen AJ
    Stem Cell Res Ther; 2016 Aug; 7(1):107. PubMed ID: 27515308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manufacturing of primed mesenchymal stromal cells for therapy.
    Yin JQ; Zhu J; Ankrum JA
    Nat Biomed Eng; 2019 Feb; 3(2):90-104. PubMed ID: 30944433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
    Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
    Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application.
    Torre ML; Lucarelli E; Guidi S; Ferrari M; Alessandri G; De Girolamo L; Pessina A; Ferrero I;
    Stem Cells Dev; 2015 Mar; 24(6):677-85. PubMed ID: 25517941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.